Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 1608-1614, 2003; 10.1373/49.10.1608
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tripodi, A.
Right arrow Articles by Pengo, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tripodi, A.
Right arrow Articles by Pengo, V.
Related Collections
Right arrow Laboratory Management
Right arrow Hemostasis and Thrombosis
(Clinical Chemistry. 2003;49:1608-1614.)
© 2003 American Association for Clinical Chemistry, Inc.

Hemostasis and Thrombosis

Lupus Anticoagulant (LA) Testing: Performance of Clinical Laboratories Assessed by a National Survey Using Lyophilized Affinity-purified Immunoglobulin with LA Activity

Armando Tripodi1,a, Alessandra Biasiolo2, Veena Chantarangkul1 and Vittorio Pengo2

1 Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine, University and IRCCS Maggiore Hospital, 20122 Milan, Italy.

2 Thrombosis Center, Department of Clinical and Experimental Medicine, Ex-Busonera Hospital, University Medical School, 35100 Padova, Italy.

aAddress correspondence to this author at: Via Pace 9, 20122 Milano, Italy. Fax 39-02-503-20723; e-mail armando.tripodi{at}unimi.it.

Background: Lupus anticoagulant (LA) screens are frequently ordered in the workup of thrombophilic patients or women with fetal loss. The sensitivity and specificity of LA detection vary depending on the choice of tests, cutoff values, and results interpretation. This variation is detrimental to patient management because persistent LA positivity in patients with a history of thrombosis is a requisite for long-term anticoagulation therapy. Numerous surveys have been performed to assess the state of the art for LA diagnosis. The control plasmas used in these surveys were from LA-positive or -negative patients or were normal plasmas with monoclonal antibodies against human ß2-glycoprotein I (ß2-GPI) added.

Methods: A large number of laboratories were asked to test a common set of lyophilized plasmas for LA, including three normal plasmas, to which increasing amounts of affinity-purified IgG from a patient positive for anti-ß2-GPI had been added, and three LA-negative plasmas: one normal, one with a coagulation deficiency, and one with heparin.

Results: Overall, 69, 68, and 59 of 70 participants were able to detect LA in plasmas with high, intermediate, and low potency (sensitivity, 99%, 97%, and 84%). Conversely, 69, 50, and 53 of 70 were able to rule out LA in the normal, heparinized, and deficient plasma (specificity, 99%, 71%, and 76%).

Conclusions: Sensitivity for LA detection is satisfactory, whereas specificity could be improved. Surveys for LA detection should be carried out on a regular basis because they may help improve performance. Plasmas containing graded amounts of affinity-purified human anti-ß2-GPI may be used as a convenient source of well-characterized naturally occurring LA material.




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Pathol.Home page
A M H P van den Besselaar, K M J Devreese, P G de Groot, and A Castel
Lupus anticoagulant: case-based external quality assessment
J. Clin. Pathol., August 1, 2009; 62(8): 731 - 734.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A Tripodi
Testing for lupus anticoagulants: all that a clinician should know
Lupus, April 1, 2009; 18(4): 291 - 298.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
A. Tripodi
Laboratory Testing for Lupus Anticoagulants: A Review of Issues Affecting Results
Clin. Chem., September 1, 2007; 53(9): 1629 - 1635.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Montaruli, A. Vaccarino, C. Foli, C. Rus, C. Agnes, M. Saitta, and M. Bazzan
Lupus Anticoagulant: Performance of a New, Fully Automated Commercial Screening and Confirmation Assay
Clin. Chem., June 1, 2005; 51(6): 1031 - 1033.
[Full Text] [PDF]

Home page
 JAMAHome page
APASS Investigators
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke
JAMA, February 4, 2004; 291(5): 576 - 584.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.